The Commission, through its Health Emergency Response and Preparedness Authority (HERA) and the European Investment Bank, has today signed a €20 million agreement with the French biopharmaceutical company Fabentech. The agreement will allow the company to develop and deploy its broad-spectrum medicines to combat biological threats to public health. The threat analysis conducted by HERA […]